LH analyst estimates
Labcorp (LH) analyst ratings, the average price target and its range, and every firm's latest call.
LH analyst ratings and price targets
| Date | Firm | Call | Target |
|---|---|---|---|
| Oct 29, 2026 | Truist Financial | Laboratory Corporation of America (LH) PT Raised to $395 at Truist Securities, 'We remain bullish' | $395.00 |
| Oct 29, 2026 | Robert W. Baird | Labcorp price target raised to $396 from $361 at Baird | $396.00 |
| Oct 29, 2026 | Morgan Stanley | Labcorp price target raised to $388 from $338 at Morgan Stanley | $388.00 |
| Oct 29, 2026 | UBS | Labcorp price target raised to $420 from $380 at UBS | $420.00 |
| Oct 29, 2026 | Deutsche Bank | Labcorp price target raised to $355 from $306 at Deutsche Bank | $355.00 |
| Oct 28, 2026 | Leerink Partners | Labcorp price target raised to $410 from $365 at Leerink | $410.00 |
| Oct 28, 2026 | Barclays | Labcorp price target raised to $380 from $330 at Barclays | $380.00 |
| Sep 21, 2026 | Truist Financial | Labcorp price target raised to $365 from $350 at Truist | $365.00 |
| Sep 11, 2026 | Barclays | Labcorp price target raised to $330 from $320 at Barclays | $330.00 |
| Sep 11, 2026 | UBS | Labcorp price target raised to $380 from $361 at UBS | $380.00 |
| Aug 10, 2026 | Mizuho Securities | Labcorp price target raised to $355 from $320 at Mizuho | $355.00 |
| Jul 31, 2026 | Robert W. Baird | Labcorp price target raised to $352 from $338 at Baird | $352.00 |
| Jul 31, 2026 | Deutsche Bank | Labcorp price target raised to $306 from $276 at Deutsche Bank | $306.00 |
| Jul 31, 2026 | Morgan Stanley | Labcorp price target raised to $338 from $308 at Morgan Stanley | $338.00 |
| Jul 30, 2026 | Barclays | Labcorp price target raised to $320 from $290 at Barclays | $320.00 |
- 9 firms rate LH: 7 buy, 2 hold, 0 sell.
- The average price target is $387.38 from 8 analysts, from $355.00 to $420.00.
Updated 2026-11-02 17:13 UTC